Noninvasive Medical Technologies (NMT) is headquartered in Las Vegas, NV. NMT manufactures its patented noninvasive hemodynamic monitors for use across the care continuum. Our clinical and administrative staff collectively has many years of development work in the field of bioimpedance application.

NMT is the only cardioplethsmograph manufacturer that incorporates the patented three-dimensional signal averaging into their technology. In addition NMT leads the world in research and development of new and innovative uses for noninvasive hemodynamic monitoring.

ldolajak@nmtinc.org

Toll Free
888.466.8552

p: 702.614.3360
f:  702.614.4170

Address
Corporate Headquarters
NMT, Inc.
6412 S. Arville St.
Las Vegas, NV 89118

International

NMT Australasia PTY LTD

ABN 29 132 406 529

p: +61 (0)404 348 887

Noninvasive Medical Technologies LTD

145-157 St. John Street

London, EC1V 4PY, UK

p: 44 20 3295 2057

Noninvasive Medical Technologies Dtl. UG

Bundesallee 171

10715 Berlin, Germany

p: 49 30 200033041

NMT and PHILIPS Collaborate to Expand Home Monitoring Capabilities for Congestive Heart Failure Patients

Philips to Market, Sell and Distribute NMT's ZOE® Fluid Status Monitor with its Patient Telemonitoring Service.

Royal Philips Electronics (NYSE: PHG, AEX: PHI) announced a reseller agreement with Noninvasive Medical Technologies, Inc. (NMT) to complement Philips’ current patient telemonitoring service offering with NMT’s ZOE® fluid monitoring technology.  According to the American Heart Association, 5.7 million people in the United States live with heart failure, a chronic condition that requires monitoring and management of fluid status.  This agreement will help support congestive heart failure patients.  Press Release

NMT's ETag Makes a Big Splash at NASA's

NEEMO 14 Mission

During Mission Day 3, the ETag team achieved one of their primary objectives on the NEEMO 14 mission. They successfully demonstrated realtime telemedicine monitoring from the Aquarius habitat back to the NEEMO 14 mission control center. This developmental technology is being used to pioneer next-generation medical monitoring by using the ETag diagnostic platform to monitor people in a variety of extreme environments, starting with the NEEMO 14 mission.

The NMT ETag is a small, credit-card-sized, radar-based medical device that is worn on the chest. The core of the technology is the TAP (Transducer Antenna Probe) which uses RFII (Radio Frequency Impedance Interrogation) to passively gather medical data from the aquanauts. It was originally developed for combat casualty care, and is now being used to monitor the aquanauts on board Aquarius.

As the aquanauts continued their NEEMO 14 mission, the ETag doctor was able to medically monitor them from land. This was the first successful technology demonstration of the mission, and a giant step forward in the potential of telemedicine. The data collected from the aquanauts includes heart rate, respiration, cardiac performance and position. The ETag also collects the environmental temperature surrounding each aquanaut.

         .                Chris A. Hadfield, a Canadian Space Agency astronaut and veteran spacewalker,

                                  Tom H. Marshburn, a NASA astronaut and flight surgeon and Dr. Steve Chappell conducting

                                  realtime telemedicine monitoring in the Aquarius Habitat.

                     Aquanaut Andrew and the Aquarius hab techs                    Dr. Marc O Griofa conducting realtime telemedicine

                     being monitored by the ETags during normal activitites      monitoring from the NEEMO 14 mission control center

To Review the NEEMO 14 Mission and view pictures and blogs from aquanauts throughout the mission please click on the links below.

Aquarius Research Station

NASA - NEEMO Mission

NMT's ETag System Participates in the NMRT's WMD Drill in Washington D.C.

On April 10, 2010, NMT participated in the National Medical Response Team's drill in our nation's capital.  The drill included preparations for incidents involving WMD, National Special Security Events (NSSE) and/or other designated major disasters, or emergencies, including public health emergencies. NMT's ETag system was deployed with both responders and casualties to continually assess and transmit vital information to the command post enabling maximized responder effectiveness and medical outcomes.

NMT's Patented ZOE Reduced 74% of CHF Readmissions through Remote Monitoring by Philips and Athens Home Health Care   

The purpose of this presentation is to demonstrate how Athens Regional Home Health successfully implemented remote telemonitoring as a part of a comprehensive disease management program for heart failure patients. The initial goals were to reduce hospital readmits and emergency department returns but benefits realized extended well beyond these goals.

Please read more about this exciting analysis CHF Readmission Results

NMT Receives the 2009 Best of Business Award

SMALL BUSINESS COMMERCE ASSOCIATION'S AWARD HONORS THE ACHIEVEMENT OF NMT IN THE MEDICAL TECHNOLOGY CATEGORY